Cite
HARVARD Citation
Cortiula, F. et al. (2022). Non-small cell lung cancer harboring EGFR G724S mutation and exon 19 deletion responded to afatinib monotherapy after multiple lines of target therapies. Anti-cancer drugs. 33 (9), pp. 960-962. [Online].